WallStreetZenWallStreetZen

NASDAQ: ALKS
Alkermes PLC Stock Ownership - Who owns Alkermes?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Alkermes PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Craig C. HopkinsonEVP RD Chief Medical Officer2026-01-085,000$19.34
$96.70kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2026-01-085,000$30.00
$150.01kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2026-01-024,000$28.00
$112.00kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2025-12-033,748$30.00
$112.45kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2025-12-033,748$19.34
$72.49kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2025-12-014,000$29.30
$117.20kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2025-11-035,000$19.34
$96.70kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2025-11-039,000$30.38
$273.44kSell
Craig C. HopkinsonEVP RD Chief Medical Officer2025-10-155,000$19.34
$96.70kBuy
Craig C. HopkinsonEVP RD Chief Medical Officer2025-10-159,000$31.53
$283.78kSell

1 of 7

ALKS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALKS insiders and whales buy or sell their stock.

ALKS Shareholders

What type of owners hold Alkermes PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.94%27,972,078$926.16MInstitution
Vanguard Group Inc11.01%18,179,511$601.92MInstitution
Price T Rowe Associates Inc6.20%10,238,357$338.99MInstitution
State Street Corp5.17%8,540,351$282.77MInstitution
Baker Bros Advisors LP4.90%8,091,351$267.90MInstitution
Elan Corp PLC4.69%7,750,000$256.60MInsider
Renaissance Technologies LLC3.81%6,292,528$208.35MInstitution
American Century Companies Inc2.66%4,397,471$145.60MInstitution
Geode Capital Management LLC2.46%4,061,394$134.47MInstitution
Jpmorgan Chase Co2.38%3,928,170$130.06MInstitution

1 of 3

ALKS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALKS93.24%6.76%Net SellingNet Selling
LNTH51.59%48.41%Net SellingNet Selling
AMRX28.65%71.35%Net SellingNet Selling
INDV99.85%0.15%Net BuyingNet Buying
PBH68.85%31.15%Net SellingNet Selling
View Top Pharmaceutical Stocks

Alkermes Stock Ownership FAQ

Who owns Alkermes?

Alkermes (NASDAQ: ALKS) is owned by 102.70% institutional shareholders, 7.45% Alkermes insiders, and 0.00% retail investors. Elan Corp PLC is the largest individual Alkermes shareholder, owning 7.75M shares representing 4.69% of the company. Elan Corp PLC's Alkermes shares are currently valued at $259.78M.

If you're new to stock investing, here's how to buy Alkermes stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.